Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts

Biochemical and Biophysical Research Communications(2023)10.1016/j.bbrc.2023.05.092Source: DataRank Database

Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts is a research paper published in Biochemical and Biophysical Research Communications (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 3.14)OA: hybridTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kameron Hahn ORCID,Santosh Kumar Duraisamy,Matthias Salathé ORCID,Steven K. Huang ORCID,Thomas P. Burris ORCID

Live enrichment

PubMed:37269594 PMC:PMC11034855 OpenAlex:https://openalex.org/W4377990460

Ian Potter Foundation

Grant: GSK41122

NIA NIH HHS

Grant: RF1 AG060769

National Heart Lung and Blood Institute Division of Intramural Research

Grant: R01 HL142543

NHLBI NIH HHS

Grant: R01 HL127203

Ian Potter Foundation

Grant: SR9011

NIGMS NIH HHS

Grant: P20 GM103418

Ian Potter Foundation

Grant: SR8278

Ian Potter Foundation

Grant: SR9009

NHLBI NIH HHS

Grant: R01 HL162963

National Institute on Aging

Grant: AG060769

Ian Potter Foundation

Grant: IL-6

University of Kansas Medical Center

National Institutes of Health

FWCI

3.14

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bbrc.2023.05.092

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37269594

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11034855

Europe_PMChttps://europepmc.org/articles/PMC11034855

Europe_PMChttps://europepmc.org/articles/PMC11034855?pdf=render

Fields of Study

Chronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisAsthma and respiratory diseases

MeSH Terms

Chronic DiseaseFibroblastsFibrosisHumansLungPhenotypeInterleukin-6Idiopathic Pulmonary FibrosisNuclear Receptor Subfamily 1, Group D, Member 1Myofibroblasts

Keywords

MyofibroblastExtracellular matrixFibrosisFibroblastIdiopathic pulmonary fibrosisPulmonary fibrosisTransforming growth factorBiologyLungCancer researchPathologyImmunologyMedicineCell biologyInternal medicineCell cultureCollagenCircadian clockTgfβSr9009Sr8278Gsk4112Rev-erbα Agonist

Sustainable Development Goals

SDG 0: Good health and well-being

Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts

FAIR Checklist

Authors (7)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)